-
MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
Tuesday, August 30, 2016 - 3:50pm | 310Read More...Biopharmaceutical company MannKind Corporation (NASDAQ: MNKD) is "making progress" in developing a less costly alternative to Mylan NV (NASDAQ: MYL)'s EpiPen. According to Connecticut-based News Times, MannKind's local manufacturing facility employs around 150 people in the city and plays a key...
-
MannKind Loses 6% Following Death Of Alfred Mann & Business Update Concerning Annual Report
Friday, February 26, 2016 - 12:29pm | 311Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading lower by 6 percent on Friday after the company sadly announced the death of Alfred E. Mann. Mann was the founder of MannKind and served as its Chairman from 2001 until February 2016. Mann also founded and largely founded 14 companies in...
